Update on antifungal drug resistance mechanisms of Aspergillus fumigatus
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 8 (6) , 344-358
- https://doi.org/10.1016/j.drup.2006.01.001
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse FungiScience, 2005
- Increased frequency of non-fumigatus Aspergillus species in amphotericin B– or triazole–pre-exposed cancer patients with positive cultures for aspergilliDiagnostic Microbiology and Infectious Disease, 2005
- Antifungal Agents: In Vitro Susceptibility Testing, Pharmacodynamics, and Prospects for Combination TherapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Aspergillus fumigatusVariant with Decreased Susceptibility to Multiple AntifungalsAntimicrobial Agents and Chemotherapy, 2004
- Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and CandidaJournal of Antimicrobial Chemotherapy, 2004
- Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patientsJournal of Medical Microbiology, 2004
- Invasive Aspergillosis in 2002: An UpdateEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive AspergillosisClinical Infectious Diseases, 2002
- Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDSClinical Infectious Diseases, 2001
- Antifungal Drug Resistance in AspergillusJournal of Infection, 2000